Catamaran (NASDAQ: CTRX) is one of 13 publicly-traded companies in the “Managed Health Care” industry, but how does it weigh in compared to its rivals? We will compare Catamaran to related businesses based on the strength of its dividends, earnings, profitability, valuation, analyst recommendations, risk and institutional ownership.
This is a summary of recent recommendations and price targets for Catamaran and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Managed Health Care” companies have a potential downside of 4.35%. Given Catamaran’s rivals higher possible upside, analysts plainly believe Catamaran has less favorable growth aspects than its rivals.
This table compares Catamaran and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Catamaran and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Catamaran Competitors||$50.73 billion||$1.52 billion||10.36|
Catamaran’s rivals have higher revenue and earnings than Catamaran. Catamaran is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Catamaran has a beta of -0.18, indicating that its stock price is 118% less volatile than the S&P 500. Comparatively, Catamaran’s rivals have a beta of 0.70, indicating that their average stock price is 31% less volatile than the S&P 500.
Institutional and Insider Ownership
90.7% of shares of all “Managed Health Care” companies are held by institutional investors. 2.4% of shares of all “Managed Health Care” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Catamaran rivals beat Catamaran on 7 of the 8 factors compared.
Catamaran Company Profile
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company’s HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with MarketBeat.com's FREE daily email newsletter.